C.F. MSTLGU48M08F631R - P.IVA 041834209699 – REA 1731503 E-MAIL: GECOSRL@GECO.191.IT MASTROMATTEI LUIGI ELABORAZIONE DATI CONTABILI INFORMATIVA N. 11/2009 Cusano M.no, 11.11.2009 NORMATIVE AZIENDE Anche quest’anno questo Studio predisporrà mensilmente la rubrica “ Normative Aziende ”. “Normative Aziende” è destinato al a clientela del o
sydneyrx2014.com Available ED Pharmacy is an 1st. pharmacy providing a individual service to the community in Australia. Over 80,000 extremely satisfied customers! We're your medication drug store levitra australia and have provided trusted service to families in Australia for over 15 years.
Sane.academyofeating.comSmoking reduction and cessation for people with schizophrenia
1 Many people with schizophrenia smoke and smoke heavily, resulting in significant Royal Australian College of General Practitioners health and lifestyle problems. Smoking reduction and cessation is complicated because smoking may alleviate some of their psychiatric symptoms and lessen the side-effects of some antipsychotics.
Assess readiness to quit (stage-of-change cycle)
2 Motivation to quit can be increased by discussing the specific costs of smoking (such as health and lifestyle issues) for that person and the benefits of quitting, as well as acknowledging the difficulties associated with quitting. A smoking history, including any past quit attempts, is useful.
Assess risks of smoking reduction and cessation
Precipitation or exacerbation of psychotic symptoms It is important to know the usual signs of relapse in that person.
Development of clinical depression Be aware of past history or family history of depression.
Smoking alters liver metabolism of some antipsychotic medications.
Write an individual plan
4 If thepatient is psychiatrically stable and wishes to commence smoking reduction and cessation, a written plan using the Guidelines available at www.health.vic.gov.au/mentalhealth/publications/smoke is important, as people
with schizophrenia may have cognitive deficits.
Use nicotine replacement
5 Nicotine withdrawal symptoms usually occur and can by very distressing. Use of nicotine replacement therapy has been shown to increase successful cessation.
At present, bupropion (Zyban) should only be used with extreme caution in this group because it carries the risk of provoking psychosis or seizures.
Recommend group support
Involvement with a specialised group program (for example, a SANE SmokeFree 6 Program) will increase reduction in smoking and quit rates, as well as assisting in Monitor frequently
7 Frequentreview initially after quitting is very important, especially with respect to mental state and medication. The person should be seen 1 to 3 days after quitting and then weekly for one month, and then monthly for six months.
Congratulate on any progress
Smokers, on average, take 5-7 attempts before they successfully cease.
8 Itis important to give credit for any gains made.
Smoking reduction and cessation for people with schizophrenia
Bob has schizophrenia, is 39 years old and has been trying to quit smoking, on and off, for the last five years. He is in regular contact with a GP and community health service. He has trouble with dizziness and is worried about weight gain if he quits (he has a family history of diabetes). A year ago, he took part in a SANE SmokeFree Program with support from his GP and psychiatrist.
He now hasn't smoked for two months, with help from nicotine gum. (He put on nearly 2 kg in the first few weeks after giving up, but is now exercising more and is only 0.5 kg above his starting weight.) He tells everyone how great he feels, and how much money he is saving, now that he has finally quit.
People with schizophrenia can quit smoking, but they may need some extra Guidelines
support and time. You can help by using these Guidelines to move your patient In Australia, tobacco smoking is the largest single preventable cause of death and disease. One in two lifetime smokers will die from diseases caused by tobacco, and half of these deaths will occur in middle age.
SANE SmokeFree Zone
Smoking rates in people with schizophrenia are up to three times those of the general population. People with schizophrenia die younger, even when factors related to their illness (such as suicide) are taken into account. They also have increased morbidity – rates of cardiovascular and respiratory disease are up to three times higher than age-matched controls.
General practitioners see about 80% of this population each year and are in a unique position to improve their quality of life. The management principles SANE SmokeFree Kit
outlined on the front of this sheet are most effectively used in conjunction with the full Guidelines: Smoking reduction and cessation for people with schizophrenia: Guidelines for general practitioners (see Resources for details).
Contact your local mental health or community health service for more information about support for people wishing to quit.
Genetic Fact Sheets for Parents Draft Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues surrounding expanded newborn screening and genetic testing – http:// www.newbornscreening.info Disorder name: Congenital Adrenal Hyperplasia Acronym: • What is CAH? • What